Chemo-enzymatic cascade processes are invaluable due to their ability to rapidly construct high-value products from available feedstock chemicals in a one-pot relay manner.In a patent, 214894-89-0, name is 5-(Bromomethyl)-2,3-dihydro-1,4-benzodioxine, introducing its new discovery. Quality Control of 5-(Bromomethyl)-2,3-dihydro-1,4-benzodioxine
Total synthesis and evaluation of [18F]MHMZ
Radiochemical labeling of MDL 105725 using the secondary labeling precursor 2-[18F]fluoroethyltosylate ([18F]FETos) was carried out in yields of ?90% synthesizing [18F]MHMZ in a specific activity of ?50 MBq/nmol with a starting activity of ?3 GBq. Overall radiochemical yield including [18F]FETos synthon synthesis, [18F]fluoroalkylation and preparing the injectable [18F]MHMZ solution was 42% within a synthesis time of ?100 min. The novel compound showed excellent specific binding to the 5-HT2A receptor (Ki = 9.0 nM) in vitro and promising in vivo characteristics.
If you are interested in 214894-89-0, you can contact me at any time and look forward to more communication. Quality Control of 5-(Bromomethyl)-2,3-dihydro-1,4-benzodioxine
Reference£º
Benzodioxan,
1,4-Benzodioxane | C8H8O2 – PubChem